VaxInnate Corporation Report issue

For profit Phase 1 Phase 2
Founded: Cranbury NJ United States (2002)
Status: Defunct (2017)

Organization Overview

First Clinical Trial
2007
NCT00603811
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 2 Trials (4)

inactivated influenza vaccine (1 trial)

vax102 (4 trials)

vax125 (2 trials)

vax2012q (3 trials)

Drugs in Phase 1 Trials (2)

vax128 (1 trial)

vax161 (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Influenza, Human (Phase 2)

Influenza in Birds (Phase 1)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 12
  • # of Trial APIs: 6